Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Earnings for Nevro Corp. (NVRO)
Earnings in 2023 (TTM): $-97,859,000
According to Nevro Corp.'s latest financial reports the company's current earnings (TTM) are $-97,859,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Nevro Corp.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-97,859,000 | $-92,213,000 |
| 2022 | $4.26 M | $3 M |
| 2021 | $-130,826,000 | $-131,360,000 |
| 2020 | $-82,197,000 | $-83,065,000 |
| 2019 | $-102,087,000 | $-103,686,000 |
| 2018 | $-48,437,000 | $-49,205,000 |
| 2017 | $-35,250,000 | $-36,658,000 |
| 2016 | $-30,155,000 | $-31,778,000 |
| 2015 | $-66,265,000 | $-67,431,000 |
| 2014 | $-30,202,000 | $-30,680,000 |
| 2013 | $-25,652,000 | $-26,014,000 |
| 2012 | $-18,805,000 | $-18,967,000 |